BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28915596)

  • 1. Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.
    Hu XQ; Chen WL; Ma HG; Jiang K
    Oncotarget; 2017 Aug; 8(34):56364-56374. PubMed ID: 28915596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers.
    Zuo T; Wilson P; Cicek AF; Harigopal M
    Hum Pathol; 2018 Oct; 80():239-245. PubMed ID: 29902579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
    Choi JE; Kang SH; Lee SJ; Bae YK
    Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
    Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Michele C; Tuccari G; Adamo V
    Oncotarget; 2017 Sep; 8(44):76974-76986. PubMed ID: 29100362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
    Riaz N; Idress R; Habib S; Lalani EN
    Front Oncol; 2020; 10():1083. PubMed ID: 32850312
    [No Abstract]   [Full Text] [Related]  

  • 6. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
    Abd-Elazeem MA; Abd-Elazeem MA
    Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis.
    Wang C; Pan B; Zhu H; Zhou Y; Mao F; Lin Y; Xu Q; Sun Q
    Oncotarget; 2016 Jul; 7(29):46482-46491. PubMed ID: 27374089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival.
    Yu L; Yu Q; Xu C; Wang M; Song J; Gao X
    Gland Surg; 2022 Nov; 11(11):1772-1783. PubMed ID: 36518802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer.
    Prabhu JS; Korlimarla A; Rajarajan S; Alexander A; Anupama C; Ramesh R; Srinath B; Sridhar TS
    Cancer Res; 2021 Feb; 81(4 Suppl):. PubMed ID: 34421401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).
    Mishra A; Mishra SK; Sharanappa V; Krishnani N; Kumari N; Agarwal G
    Indian J Surg Oncol; 2024 Jun; 15(2):250-257. PubMed ID: 38741650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.
    Millis SZ; Gatalica Z; Winkler J; Vranic S; Kimbrough J; Reddy S; O'Shaughnessy JA
    Clin Breast Cancer; 2015 Dec; 15(6):473-481.e3. PubMed ID: 26051240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study.
    Sridhar N; Glisch C; Jawa Z; Chaudhary LN; Kamaraju S; Burfeind J; Charlson J; Chitambar CR; Jorns JM; Cheng YC
    J Cancer; 2022; 13(8):2472-2476. PubMed ID: 35711833
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival.
    Mansouri H; Alcaraz LB; Mollevi C; Mallavialle A; Jacot W; Boissière-Michot F; Simony-Lafontaine J; Laurent-Matha V; Roger P; Liaudet-Coopman E; Guiu S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
    Loibl S; Müller BM; von Minckwitz G; Schwabe M; Roller M; Darb-Esfahani S; Ataseven B; du Bois A; Fissler-Eckhoff A; Gerber B; Kulmer U; Alles JU; Mehta K; Denkert C
    Breast Cancer Res Treat; 2011 Nov; 130(2):477-87. PubMed ID: 21837479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the androgen receptor in triple-negative breast cancer.
    Rampurwala M; Wisinski KB; O'Regan R
    Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer.
    Kim EY; Lee KH; Yun JS; Park YL; Park CH; Do SI; Chae SW
    Int J Clin Exp Pathol; 2017; 10(7):7929-7939. PubMed ID: 31966643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].
    Svoboda M; Navrátil J; Fabian P; Palácová M; Gombošová J; Slámová L; Princ D; Syptáková B; Kudláček A; Bílek O; Pospíšil P; Kazda T; Grell P; Poprach A; Selingerová I; Nenutil R; Juráček J; Héžová R; Slabý O; Vyzula R
    Klin Onkol; 2012; 25(3):188-98. PubMed ID: 22724568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Varhaug JE; Skarstein A; Kvinnsland S
    Eur J Surg Oncol; 1992 Apr; 18(2):112-8. PubMed ID: 1582503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of androgen receptors in triple negative breast carcinomas.
    Mrklić I; Pogorelić Z; Capkun V; Tomić S
    Acta Histochem; 2013 May; 115(4):344-8. PubMed ID: 23031358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.